Are You Looking For Opportunity on Stock? Cleveland BioLabs (CBLI)

Cleveland BioLabs (CBLI) Stock’s Price Fluctuations & Volatility:

The stock price registered volatility 21.55% in past week and volatility was at 10.37% over a last month. Historical volatility refers to the price fluctuations exhibited by the underlying asset (such as stock) over time. A security with high volatility has bigger fluctuations in price compared to a security with low volatility. The more quickly a price changes up and down, the more volatile it is. As such, volatility is often used as a measure of risk.

The stock’s Average True Range for 14 days was 0.18. ATR measures volatility, taking into account any gaps in the price movement. High ATR indicates increased volatility. A low ATR value indicates a series of periods with small ranges. Company’s beta coefficient stands at 0.56. Beta factors measures the amount of market risk associated with market trade. Presently, the stock has a RSI reading of 60.24.

Cleveland BioLabs (CBLI) Stock’s Ratio Analysis:

It has kept Return on investment (ROI) at 320.00%. ROI is a financial ratio intended to measure the benefit obtained from an investment. Time is usually of the essence in this measurement because it takes time for an investment to realize a benefit.

Its current ratio is 4.9. Current Ratio is a liquidity ratio that measures a company’s ability to pay short-term obligations. Quick Ratio of 4.9 is an indicator of a company’s short-term liquidity. The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets. The higher the quick ratio, the better the position of the company.

Let’s consider Cleveland BioLabs (CBLI) stock move that changed on Wednesday Dated MARCH 13, 2019. 3845 shares changed at hands in last session versus to an average volume of 12.21K shares. Cleveland BioLabs (CBLI) stock ended at $1.74 by scoring 1.04%. It has 13.22M outstanding shares and 4.73M shares have been floated in market exchange. The stock institutional ownership included 5.50% while insider ownership remained 58.15%. The net percent change held by Institutional Investors has seen a change of -7.97% over last three month period. The net percent change kept by insiders has seen a change of 0.00% over last six month period.

Cleveland BioLabs (CBLI) Stock’s Moving Average & Performance Analysis:

The stock showed weekly performance of 36.42% and it maintained for the month at 19.86%. Likewise the performance for the quarter was recorded as -2.91% and for the year it was -48.43%. The stock showed -4.51% performance during last 6-months. The YTD performance remained at 72.07%. This stock traded up toward its 52 week low with 73.79% and -51.46% down from its 52 week high price. The stock price is moving higher from its 20 days moving average with 21.10% and it is trading up from 50 days moving average with 24.03%. The stock price is moving along downward drift from its 200 days moving average with -8.70%.

Mark Fife

Mark Fife

Mark Fife has an experience in Journalism and Content Writing, love writing stories full of efficient language and accurate content. He is a graduate of University of Sydney and has two years’ experience of Wall Street Investor. Mark covers Business category. His articles are published on Seeking Alpha, The Street, and The Motley Fool. Brianna has over 4 year experience as a news writer. Previously, he worked as a tech news reporter. Email Contact:

Leave a Reply

Your email address will not be published. Required fields are marked *

Solve : *
24 − 9 =